Search results
Geron wins long-sought drug approval; Califf talks China, GLP-1s at BIO
BioPharma Dive via Yahoo Finance· 7 days agoAfter 34 years, Geron finally has an approved medicine in Rytelo. Elsewhere, Shionogi disclosed...
Geron Shares Surge After U.S. FDA Approves Blood Disorder Drug
US News & World Report· 7 days agoThe injectable drug will compete with Bristol Myers Squibb's Reblozyl, which received a label expansion green light by the regulator last year for the same disease indication. California-based ...
7 Stocks Warren Buffett Has Sold in the Past Year (and You Should Too)
InvestorPlace· 4 days agoThe Oracle of Omaha is by far the most well-known long-term investor we have alive today, and if you...
Alumis readies IPO to fund rival drug to Bristol Myers’ Sotyktu
BioPharma Dive via Yahoo Finance· 4 days agoDive Brief: Biotechnology startup Alumis on Friday outlined plans for an initial public offering...
Chutes & Ladders—Sanofi research head Frank Nestle says au revoir
FierceBiotech· 7 days agoPlease send the good word—or the bad—from your shop to Gabrielle Masson and it will be featured here...
Taye Diggs’ Champions Wellness Campaign After Sister Diagnosed With Schizophrenia
Black America Web· 4 days agoTaye Diggs is shining a spotlight on schizophrenia after his younger sister Christian was diagnosed...
Geron surges after winning first US FDA approval for blood disorder drug
Colorado Springs Gazette· 7 days agoThe health regulator's nod allows the injectable drug, branded as Rytelo, to be used for treating transfusion-dependent anemia in patients with lower-risk myelodysplastic syndromes (MDS), a ...
Geron (GERN) Wins FDA Approval for Blood Cancer Drug, Stock Up
Zacks via Yahoo Finance· 4 days agoGeron's (GERN) shares rise on approval of its first drug. The FDA approves imetelstat for the...
Tech Hubs Sprout Innovation
New Jersey Business Magazine· 5 days agoThe HELIX in New Brunswick, a $2-billion life science center that aims to be a leader of translational research in New Jersey and throughout the East...
Experts Focus on Quality-of-Life Data in Prostate Cancer
Medscape· 3 days agoSeveral trials presented at ASCO 2024 explored strategies to improve quality of life in patients with prostate cancer.